Q1 2026 · 13F-HR
First Light Asset Management, LLCholdings as filed
Filed 2026-05-15 · accession 0001999371-26-010896
$1.12B
Reported value
35
Positions
2026-03-31
Period end
The Brief · First Light Asset Management, LLC · Q1 2026
AI · grounded in 13F
First Light Asset Management, LLC closed its position in IRON for a reduction of $41.5M. The fund also exited its holding in MDGL for $38.9M and trimmed its stake in VERA by 63.9%. On the buy side, the fund established new positions in TLSI for $20.3M and TECX for $20M. Additionally, it increased its share count in APGE by 102.4%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 05463X106 | AXGN | AXOGEN INC | $132.6M | 11.9% | 4,002,768 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC | $122.3M | 11.0% | 980,758 | Common | SOLE |
| 64049M209 | NEO | NEOGENOMICS INC | $72.2M | 6.47% | 9,729,978 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $67.6M | 6.06% | 5,353,190 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS LIMITED | $62.0M | 5.56% | 1,560,991 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $48.5M | 4.35% | 576,684 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $44.3M | 3.97% | 3,190,645 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORPORATION | $41.8M | 3.74% | 878,848 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS INC | $39.6M | 3.55% | 1,089,670 | Common | SOLE |
| 65443P102 | MASS | 908 DEVICES INC | $37.2M | 3.33% | 6,072,563 | Common | SOLE |
| 641288105 | NPCE | NEUROPACE INC | $32.3M | 2.90% | 2,459,966 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $31.6M | 2.83% | 1,001,846 | Common | SOLE |
| 032724106 | ANAB | ANAPTYS BIO INC | $31.4M | 2.81% | 565,431 | Common | SOLE |
| 829214105 | SLP | SIMULATIONS PLUS INC | $31.1M | 2.79% | 2,632,823 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH | $25.9M | 2.32% | 280,299 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $25.2M | 2.26% | 1,314,715 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $20.8M | 1.87% | 729,521 | Common | SOLE |
| 89680M101 | TLSI | TRISALUS LIFE SCIENCES INC | $20.3M | 1.82% | 5,066,827 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTICS INC | $20.0M | 1.79% | 647,743 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES | $19.8M | 1.78% | 168,116 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $17.6M | 1.58% | 732,860 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HOLDINGS | $17.5M | 1.57% | 307,738 | Common | SOLE |
| 42225T107 | HCAT | HEALTH CATALYST INC | $16.4M | 1.47% | 12,878,700 | Common | SOLE |
| 68213N109 | OMCL | OMNICELL INC | $16.4M | 1.47% | 489,846 | Common | SOLE |
| 759910102 | KRMD | KORU MEDICAL SYSTEMS INC | $16.3M | 1.46% | 3,768,380 | Common | SOLE |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $15.6M | 1.40% | 242,927 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $13.4M | 1.20% | 1,843,968 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $12.6M | 1.13% | 313,906 | Common | SOLE |
| 602496101 | MDXG | MIMEDX GROUP INC | $11.2M | 1.01% | 2,842,892 | Common | SOLE |
| 124155102 | BFLY | BUTTERFLY NETWORK INC | $10.7M | 0.96% | 2,660,167 | Common | SOLE |
| 85220G109 | SGP | SPYGLASS PHARMA INC | $9.7M | 0.87% | 375,000 | Common | SOLE |
| 68621F102 | ORGO | ORGANOGENESIS HOLDINGS INC | $8.3M | 0.74% | 3,498,533 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $8.2M | 0.74% | 141,784 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $7.9M | 0.71% | 201,867 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $7.6M | 0.68% | 87,181 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.